Clinical Trial Update: Different Oral Doses of Clindamycin in Preventing Post-operative Sequelae of Lower Third Molar Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing different oral doses of clindamycin to prevent post-operative sequelae after lower third molar surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impacted Molar
• Impacted Third Molar

Drugs mentioned

• Clindamycin

Snippet

Sponsor: Oral and Maxillofacial Surgery Clinic, Poland | Conditions: Impacted Third Molar Tooth, Impacted Molar | Phase 4 | Status: UNKNOWN